Nova Biopharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 29-06-2024
- Paid Up Capital ₹ 0.10 M
as on 29-06-2024
- Company Age 15 Year, 10 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.25 M
as on 29-06-2024
- Revenue -6.85%
(FY 2021)
- Profit -97.98%
(FY 2021)
- Ebitda -31.95%
(FY 2021)
- Net Worth 1.00%
(FY 2021)
- Total Assets 31.60%
(FY 2021)
About Nova Biopharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.25 M.
Pushpa Daga and Jyoti Daga serve as directors at the Company.
- CIN/LLPIN
U24232RJ2009PTC030484
- Company No.
030484
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Dec 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Jodhpur, Rajasthan, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Nova Biopharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pushpa Daga  | Director | 11-Apr-2011 | Current |
| Jyoti Daga | Director | 14-Dec-2009 | Current |
Financial Performance of Nova Biopharma.
Nova Biopharma Private Limited, for the financial year ended 2021, experienced Minor drop in revenue, with a 6.85% decrease. The company also saw a substantial fall in profitability, with a 97.98% decrease in profit. The company's net worth moved up by a moderate rise of 1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nova Biopharma?
In 2020, Nova Biopharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 17 Feb 2023 | ₹1.25 M | Open |
How Many Employees Work at Nova Biopharma?
Unlock and access historical data on people associated with Nova Biopharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nova Biopharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nova Biopharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
